You are here

Article Text

Article menu
Download PDFPDF
Short report
The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population
  1. Florian Grabellus1,
  2. Karl Worm1,
  3. Sien-Yi Sheu1,
  4. Winfried Siffert2,
  5. Kurt W Schmid1,
  6. Hagen S Bachmann2
  1. 1Institute of Pathology and Neuropathology, University Hospital Essen, Essen, Germany
  2. 2Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
  1. Correspondence to Florian Grabellus, Institute of Pathology and Neuropathology, University Hospital Essen, Hufelandstrasse 55, Essen 45122, Germany; florian.grabellus{at}uk-essen.de

Abstract

Background The frequency of the c-kit exon 10 variant, M541L, (c.1621 A>C) in aggressive fibromatosis (AF) was recently determined to be 2.5-fold higher than in healthy controls. It was thus hypothesised that M541L could be associated with the development of AF.

Methods 42 cases of sporadic AF were investigated for c-kit exon 10 alterations, by traditional sequencing. Subsequently, the AF cases and 126 healthy volunteers were screened for the M541L by pyrosequencing.

Results Genotype frequency of M541L in AF was 16.7% (allele frequencies: A, 0.92 and C, 0.08), which did not differ from the control group. Moreover the M541L variant was found to be not tumour specific.

Conclusions The result classifies the M541L variant of c-kit exon 10 as a single nucleotide polymorphism. Because its prevalence does not differ between the AF and general populations, an association with AF tumourigenesis is unlikely.

  • Soft tissue tumours

https://doi.org/10.1136/jcp.2011.090498

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.